- Home
- BFRI vs OXBR Comparison
BFRI vs OXBR Comparison
Compare BFRI & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BFRI | OXBR |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 11.6M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BFRI | OXBR |
|---|---|---|
| Price | $0.82 | $1.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.75 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 130.7K | 17.7K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $37,164,000.00 | $2,423,000.00 |
| Revenue This Year | $9.70 | $497.99 |
| Revenue Next Year | $10.97 | $42.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.11 | N/A |
| 52 Week Low | $0.54 | $1.12 |
| 52 Week High | $1.87 | $5.81 |
Technical Indicators
Market Signals| Indicator | BFRI | OXBR |
|---|---|---|
| Relative Strength Index (RSI) | 42.82 | 51.12 |
| Support Level | $0.77 | $1.30 |
| Resistance Level | $0.87 | $1.42 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 59.46 | 82.67 |
Price Performance
Historical ComparisonAbout BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.